Biomaterials could mean better vaccines, virus-fighting surfaces

"Toward the very end of his life, he was treated with monoclonal antibodies, from Regeneron," Li says. "And shortly thereafter, we saw evidence that suggested the virus was developing resistance or escaping from these antibodies as well."

All These Mutant Virus Strains Need New Code Names

South Africa suspends use of AstraZeneca’s COVID-19 vaccine after it fails to clearly stop virus variant